Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yosuke Horita
Observed names:
Horita Yosuke,
Horita, Yosuke,
Y. Horita,
YOSUKE HORITA
Institutions:
Saitama International Medical Center,
Saitama Medical University
Observed institutions:
Kyushu University,
National Cancer Centre Japan,
Toyama Prefectural Central Hospital,
Saitama International Medical Center,
National Cancer Center Hospital,
Saitama Medical University
show all 6
ORCID:
0000-0003-2352-2234
Observed ORCID:
0000-0003-2352-2234
OpenAlex ID:
A5011322449
Mesenteric phlebosclerosis associated with long‐term oral intake of geniposide, an ingredient of herbal medicine
2012
·
K. Hiramatsu
, H. Sakata
, et al.
·
Alimentary Pharmacology & Therapeutics
·
97
PDF
Pharmacokinetic parameters from 3‐Tesla DCE‐MRI as surrogate biomarkers of antitumor effects of bevacizumab plus FOLFIRI in colorectal cancer with liver metastasis
2011
·
Yoshinori Hirashima
, Yasuhide Yamada
, et al.
·
International Journal of Cancer
·
72
Gastric adenocarcinoma of the fundic gland (chief cell-predominant type): A review of endoscopic and clinicopathological features
2016
·
Masaki Miyazawa
, Mitsuru Matsuda
, et al.
·
World Journal of Gastroenterology
·
57
Biomarkers of reactive resistance and early disease progression during chemotherapy plus bevacizumab treatment for colorectal carcinoma
2014
·
Hidetoshi Hayashi
, Tokuzo Arao
, et al.
·
Oncotarget
·
42
PDF
Clinical Validity of Plasma-Based Genotyping for Microsatellite Instability Assessment in Advanced GI Cancers: SCRUM-Japan GOZILA Substudy
2022
·
Yoshiaki Nakamura
, Wataru Okamoto
, et al.
·
JCO Precision Oncology
·
33
Impact of UGT 1A1 genetic polymorphism on toxicity in unresectable pancreatic cancer patients undergoing FOLFIRINOX
2018
·
Hiromichi Shirasu
, Akiko Todaka
, et al.
·
Cancer Science
·
30
PDF
Phase II clinical trial of second-line FOLFIRI plus bevacizumab for patients with metastatic colorectal cancer: AVASIRI trial
2011
·
Yosuke Horita
, Yasuhide Yamada
, et al.
·
International Journal of Clinical Oncology
·
29
Nationwide Multicenter Observational Study of FOLFIRINOX Chemotherapy in 399 Patients With Unresectable or Recurrent Pancreatic Cancer in Japan
2018
·
Akiko Todaka
, Nobumasa Mizuno
, et al.
·
Pancreas
·
20
An Autopsy Case of Late-onset Fulminant Myocarditis Induced by Nivolumab in Gastric Cancer
2022
·
Ken Naganuma
, Yosuke Horita
, et al.
·
Internal Medicine
·
19
PDF
Clinical Validation of Plasma-Based Genotyping for RAS and BRAF V600E Mutation in Metastatic Colorectal Cancer: SCRUM-Japan GOZILA Substudy
2023
·
Yu Aoki
, Yoshiaki Nakamura
, et al.
·
JCO Precision Oncology
·
16
PDF
Efficacy of Targeted Trials and Signaling Pathway Landscape in Advanced Gastrointestinal Cancers From SCRUM-Japan GI-SCREEN: A Nationwide Genomic Profiling Program
2023
·
Yoshiaki Nakamura
, Riu Yamashita
, et al.
·
JCO Precision Oncology
·
14
PDF
Expression of LAT1 and 4F2hc in Gastroenteropancreatic Neuroendocrine Neoplasms
2021
·
YOSUKE HORITA
, KYOICHI KAIRA
, et al.
·
In Vivo
·
12
PDF
Phase II clinical trial of second-line weekly paclitaxel plus trastuzumab for patients with HER2-positive metastatic gastric cancer
2018
·
Yosuke Horita
, Michiko Nishino
, et al.
·
Anti-Cancer Drugs
·
11
Effects of bevacizumab on plasma concentration of irinotecan and its metabolites in advanced colorectal cancer patients receiving FOLFIRI with bevacizumab as second-line chemotherapy
2009
·
Yosuke Horita
, Y. Yamada
, et al.
·
Cancer Chemotherapy and Pharmacology
·
11
Microbiome Landscape and Association with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors: A SCRUM-Japan MONSTAR-SCREEN Study
2025
·
Kentaro Sawada
, Riu Yamashita
, et al.
·
Cancer Research Communications
·
10
PDF
Verification of the Utility of Palliative Radiotherapy for Hemostasis of Gastric Cancer Bleeding: a Case Control Study
2021
·
Hirofumi Sugita
, Shinichi Sakuramoto
, et al.
·
Journal of Gastrointestinal Cancer
·
10
Molecular Biomarker Study in a Randomised Phase III Trial of Irinotecan Plus S-1 versus S-1 for Advanced Gastric Cancer (GC0301/TOP-002)
2016
·
A. Tsuburaya
, N. Sugimoto
, et al.
·
Clinical Oncology
·
10
PTEN-induced kinase 1 gene single-nucleotide variants as biomarkers in adjuvant chemotherapy for colorectal cancer: a retrospective study
2023
·
Yoshiaki Mihara
, Masataka Hirasaki
, et al.
·
BMC Gastroenterology
·
9
PDF
FOLFIRINOX as second-line chemotherapy for advanced pancreatic cancer: A subset analysis of data from a nationwide multicenter observational study in Japan
2020
·
Noritoshi Kobayashi
, Katsuhiro Omae
, et al.
·
Pancreatology
·
9
Undifferentiated pleomorphic sarcoma in a patient with Cowden syndrome after radiotherapy for breast cancer
2018
·
Naohito Hatta
, Yosuke Horita
·
The Journal of Dermatology
·
9
FOLFIRINOX in Pancreatic Cancer: Risk Factors for Febrile Neutropenia and Severe Neutropenia — Nationwide Study Analysis
2023
·
AKIKO TODAKA
, MITSUHITO SASAKI
, et al.
·
Anticancer Research
·
6
PDF
A Prospective, Multicenter Phase II Study of the Efficacy and Feasibility of 15-minute Panitumumab Infusion Plus Irinotecan for Oxaliplatin- and Irinotecan-refractory, KRAS Wild-type Metastatic Colorectal Cancer (Short Infusion of Panitumumab Trial)
2017
·
Kohei Akiyoshi
, Tetsuya Hamaguchi
, et al.
·
Clinical Colorectal Cancer
·
5
NOTCH gene alterations in metastatic colorectal cancer in the Nationwide Cancer Genome Screening Project in Japan (SCRUM-Japan GI-SCREEN)
2022
·
Takeshi Kajiwara
, Tomohiro Nishina
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
3
PDF
Wernicke encephalopathy in a caregiver: A serious physical issue resulting from stress in a family member caring for an advanced cancer patient
2021
·
Mayumi Ishida
, Nozomu Uchida
, et al.
·
Palliative & Supportive Care
·
3
Clinicopathological characteristics of surgically treated patients with non-B non-C type hepatocellular carcinoma
2010
·
Tomoyuki Hayashi
, Satoshi Hirai
, et al.
·
Kanzo
·
3
PDF
Show more works
View as search
Works count:
80
Citation count:
561
H-index:
12
I10-index:
17
Year
Topic
Type